Author:
Sers ̌a G.,C ̌emaz ̌ar M.,Parkins C.S.,Chaplin D.J.
Reference36 articles.
1. Brown JM. Exploitation of bioreductive agents with vasoactive drugs. In Fiedlen EM, Fowler JF, Hendry JH, Scott D, eds. Proceedings of the Eighth International Congress on Radiation Research, Edinburgh UK, Vol. 2. London, Taylor and Francis, 1987, 719–724.
2. The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain;Chaplin;Int. J. Radiat. Oncol. Biol. Phys.,1987
3. Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine;Stratford;Br. J. Cancer,1988
4. Vascular occlusion and tumour cell death;Denekamp;Eur. J. Cancer Clin. Oncol.,1983
5. The influence of tumor temperature on ischemia-induced cell death: potential implications for the evaluation of vascular mediated therapies;Chaplin;Radiother. Oncol.,1994
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献